This compound is a chiral pharmaceutical intermediate featuring a tetracyclic structure with chlorine and ether functional groups. It is primarily utilized in the synthesis of active pharmaceutical ingredients.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 129385-59-7
(3aR,12bR)-rel-5-Chloro-2,3,3a,12b-tetrahydro-2-methyl-1H-dibenz[2,3
research compound
(2S,6R)-9-chloro-4-methyl-13-oxa-4-azatetracyclo[12.4.0.02,6.07,12]octadeca-1(18),7(12),8,10,14,16-hexaen-3-one
pharmaceutical intermediate
3-Amino-2,6-dichloro-4-methylpyridine
Pharmaceutical intermediate
((2R,3R,4R)-3-((4-Chlorobenzoyl)oxy)-4-fluoro-4-methyl-5-oxotetrahydrofuran-2-yl)methyl 4-chlorobenzoate
Pharmaceutical intermediate for sofosbuvir
[(2R,3R,4R,5R)-5-BROMO-3-(4-CHLOROBENZOYLOXY)-4-FLUORO-4-METHYLOXOLAN-2-YL]METHYL 4-CHLOROBENZOATE
Pharmaceutical intermediate
(2R,3R,4R,5R)-5-(2-amino-6-chloro-9H-purin-9-yl)-2-[(4-chlorobenzoyloxy)methyl]-4-fluoro-4-methyloxolan-3-yl 4-chlorobenzoate
pharmaceutical intermediate
(2S,6S)-17-chloro-4-methyl-13-oxa-4-azatetracyclo[12.4.0.02,6.07,12]octadeca-1(14),7,9,11,15,17-hexaen-3-one
OOUVAHYYJVOIIB-CZUORRHYSA-N
CN1C[C@H]2[C@H](C1=O)C3=C(C=CC(=C3)Cl)OC4=CC=CC=C24
—